FdaApplication
NDA 203756
Identifiers
- fda_app_no: NDA203756
Properties
| Property | Value |
|---|---|
| applicant_name | EXELIXIS INC |
| application_type | NDA |
| approval_date | 2012-11-29 |
Products (2)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| COMETRIQ | CABOZANTINIB S-MALATE | EQ 80MG BASE | CAPSULE;ORAL |
| COMETRIQ | CABOZANTINIB S-MALATE | EQ 20MG BASE | CAPSULE;ORAL |
2 products